Vir Biotechnology: Executives
Marianne De Backer, M.Sc., Ph.D., MBAPresident, Chief Executive Officer and DirectorFY2025
Mark Eisner, M.D., M.P.H.Executive Vice President and Chief Medical OfficerFY2025
Jason O’Byrne, MBAExecutive Vice President and Chief Financial OfficerFY2025
Vanina de Verneuil, J.D.Executive Vice President, General Counsel and Corporate SecretaryFY2025
4 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.